Whole-genome sequencing revealed independent emergence of vancomycin-resistant Enterococcus faecium causing sequential outbreaks over 3 years in a tertiary care hospital. by Abdelbary, MHH et al.
VRE_Manuscript_Revised2.docx  1 
Whole-genome sequencing revealed independent emergence of 1 
vancomycin-resistant Enterococcus faecium causing sequential 2 
outbreaks over three years in a tertiary care hospital 3 
 4 
Mohamed H.H Abdelbary1, Laurence Senn1, Gilbert Greub2, Gregory Chaillou1, Estelle 5 
Moulin1, Dominique S. Blanc1 6 
 7 
1. Service of hospital preventive medicine, Lausanne University Hospital, Lausanne, 8 
Switzerland 9 
2. Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland 10 
 11 
Key words: Enterococcus faecium, genome sequencing, outbreak, vancomycin 12 
resistance, transmission, infection control 13 
 14 
Corresponding author: 15 
Dominique Blanc 16 
Service of Hospital Preventive Medicine 17 
Lausanne University Hospital 18 
Rue du Bugnon 46 19 
1011 Lausanne, Switzerland 20 
e-mail: Dominique.Blanc@chuv.ch 21 
  22 
VRE_Manuscript_Revised2.docx  2 
 23 
Abstract 24 
Vancomycin‐resistant Enterococcus faecium (VREfm) emerged as an important cause 25 
of nosocomial infections worldwide. Previous studies based on molecular typing 26 
revealed that VREfm outbreaks are mainly associated with a particular genetic lineage, 27 
namely clonal complex 17 (CC17), which harbours either vanA or vanB gene cluster. 28 
The University Hospital of Lausanne faced several VREfm episodes of transmissions 29 
between 2014 and 2017. In this study, we used whole-genome sequencing (WGS) to 30 
investigate the relatedness of 183 VREfm isolates collected from 156 patients. 31 
Sequence type (ST) 17, ST80 and ST117 were the most predominant clones. Based 32 
on epidemiological data, 10 outbreaks were identified, which were caused by at least 33 
13 distinct genotypes. The majority of isolates involved in outbreaks (91%) differed by 34 
only 0 to 3 SNPs. Four outbreaks involved more than one genotype and half of the 35 
cases considered as sporadic were possibly linked to an outbreak. By sequencing all 36 
isolates, we were able to better understand our local epidemiology of VREfm. The 37 
polyclonal structure observed between the different outbreaks strains, the high level of 38 
recombination detected in isolates, the time elapsed between admission and the first 39 
VREfm detection and the negative screening at admission support the hypothesis of 40 
the emergence of new VREfm clones within the hospitalized population. 41 
  42 
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Introduction 43 
Vancomycin-resistant Enterococcus faecium (VREfm) colonization and infection 44 
represent a major problem mostly in the hospital setting. Since VREfm was first 45 
reported in 1988 in the United Kingdom and in France, it emerged worldwide causing 46 
outbreaks (1, 2). Patients infected by VREfm are likely to have longer hospitalization 47 
stays and exhibit higher mortality rates compared to vancomycin-susceptible infections 48 
(3, 4). In addition, asymptomatic VREfm colonized patients can serve as potential 49 
sources for transmission and environmental contamination. 50 
VREfm belonging to clonal complex 17 (CC17) has been successfully disseminated in 51 
hospital settings and became endemic in many countries. E. faecium encode 52 
resistance to vancomycin through of van gene clusters of either type A (vanA) or B 53 
(vanB). Previous studies have shown that VREfm with vanA type are widely spread in 54 
the United States, Europe, Korea, Africa and South America, while VREfm with vanB 55 
are predominant in Australia and Singapore (5). 56 
Transmission is suspected when two or more VREfm-positive patients are identified in 57 
the same unit during an overlapping period. Genotyping of isolates should complement 58 
this epidemiological approach, especially when whole-genome sequencing techniques 59 
are used, providing greater discrimination between isolates (6-8). 60 
Here, we report the findings of a prospective study of several sequential VREfm 61 
outbreaks, which occurred between 2014 and 2017 at the University Hospital of 62 
Lausanne, Switzerland. Whole genome sequencing (WGS) was used to assess the 63 
genetic relatedness among 183 VREfm isolates collected from 156 patients during this 64 
period. In addition, we investigated the evolution of VREfm within individual long-term 65 
carriers. 66 
  67 
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Materials and methods 68 
Setting, case definition and infection control measures. The University Hospital of 69 
Lausanne is a 1100-bed tertiary care hospital with 1 to 5-bedrooms, which faced 70 
several VRE outbreaks in 2011, 2015 and 2016. A case was defined as a patient 71 
colonized/infected with VREfm during a hospitalization stay. All VRE cases were 72 
placed on contact isolation. Contact patients (i.e. patients who shared the same room 73 
or the same open unit of a new VRE case during at least 24 hours in the last month) 74 
were screened and placed on contact isolation until at least 3 rectal samples taken a 75 
week apart were found negative for VRE. When one or more contacts were found 76 
positive, all patients from the unit were screened on a weekly basis and at discharge 77 
until no new case was revealed.  78 
Laboratory. Screening for VRE was performed by culturing a rectal swab or a stool 79 
sample in an enrichment brain–heart infusion with 3.3 mg/L of vancomycin and 80 
chromogenic selective agar plates (Biorad, Marnes la Coquette, France). Identification 81 
was confirmed with MALDI-TOF mass spectrometer (Bruker, Daltonics, Germany) and 82 
the presence of the van genes was assessed using the Xpert vanA/vanB rapid test 83 
(Cepheid, Sunnyvale, CA, USA). At least one isolate per patient was stored at -80 °C 84 
for further analysis. 85 
Epidemiological definition. Epidemiological links between cases were considered i) 86 
between a new case and positive patients identified following the screening of contact 87 
patients, ii) new cases identified in the same unit during weekly screening and iii) after 88 
reviewing the hospitalisation chart of patients and the detection of links with VRE-89 
positive cases during previous hospitalisation. An outbreak was defined as two or more 90 
cases with epidemiological links. A case with no epidemiological links was considered 91 
as a single case. 92 
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Bacterial isolates. In this study, we analysed a total of 183 consecutive VREfm 93 
isolates. They were collected during successive outbreaks occurring between January 94 
2014 and May 2017 at the University hospital of Lausanne. For only 10 patients, the 95 
VREfm was detected in a clinical sample, for the others patients, the VRE (n=146) 96 
were detected from screening samples (Table S1). 97 
Whole-genome sequencing. Genomic DNA of isolates was extracted using the 98 
Wizard Genomic DNA Purification kit (Promega, Madison, WI, USA) according to the 99 
manufacturer’s instructions. The extracted DNA was quantified by the Qubit double-100 
stranded DNA high-sensitivity (HS) assay kit (Life Technologies, Waltham, MA, USA). 101 
Sequencing library preparation was carried out using Nextera XT DNA Library 102 
Preparation Kit (Illumina, San Diego, CA, USA) with indexed adapters, following the 103 
manufacturer’s guidelines, followed by sequencing using version 2 chemistry protocol 104 
on the Illumina MiSeq platform (Illumina, San Diego, CA, USA) to generate 150 bp 105 
paired-end reads. 106 
Sequence data analysis and core-genome phylogeny. In silico multi-locus 107 
sequence typing (MLST) analysis and identification of STs were performed using 108 
SRST2 pipeline (9). Sequence reads of the 183 VREfm were mapped to the VREfm 109 
reference genome AUS004 (GenBank accession number: NC-017022) using Snippy 110 
version 3.1 pipeline (https://github.com/tseemann/snippy). Furthermore, Snippy used 111 
BWA-MEM version 0.7.15 (10) for aligning reads against the reference genome, while 112 
Freebayes version 1.0.2 (11) was used for variant calling. Single nucleotide 113 
polymorphisms (SNPs) were identified based on the following parameters: first, a 114 
minimum read coverage of 10 x, a minimum base quality score of 30, and a minimum 115 
proportion for variant evidence of 0.9. SNPs found within the core-genome of the 183 116 
VREfm isolates (1,755,155 bp in size) were included, while SNPs located within mobile 117 
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genetic elements and repetitive regions were excluded. Briefly, mobile genetic 118 
elements such as insertion sequences, transposons, and conjugative plasmids were 119 
identified from the reference genome annotations AUS004 (GenBank accession 120 
numbers: NC-017022) and the repeat-match algorithm that is implemented in MUMmer 121 
package version 3.23 (12), while putative prophages and repetitive regions were 122 
identified using PHAST (phast.wishartlab.com). Gubbins version 2.2.2 (13) with default 123 
settings was used to identify and exclude regions of high SNPs densities and 124 
suspected to undergo recombination events based on the isolates’ phylogeny. 125 
Subsequently, the final alignment of non-recombinant core genome SNPs was 126 
generated and used to construct a maximum likelihood phylogenetic tree using PhyML, 127 
which was visualized with the Seaview software version 4.6 (14).  128 
A cluster was defined as a group of isolates showing a high degree of similarity based 129 
on SNPs analysis, suggesting they belong to the same chain of transmission. 130 
Detection of antibiotic resistance and virulence genes. The determination of 131 
acquired resistance and putative virulence genes were performed through mapping 132 
and from de novo assembled using both SRST2 and ARIBA (rapid antimicrobial 133 
resistance genotyping directly from sequencing reads) 134 
(http://www.biorxiv.org/content/early/2017/03/18/118000) with default settings, 135 
respectively. Furthermore, the public databases ARG- ANNOT 136 
(http://en.mediterranee-infection.com/article.php?laref=283&titre=arg-annot) and 137 
CARD (15) were used as a reference for detecting the antimicrobial resistance 138 
determinants, while the VFDB database (16) was used for identifying the virulence 139 
factor genes. To study the genetic variation within vanA and vanB transposons among 140 
the investigated isolates, sequence reads were mapped against Tn1549 (ENA 141 
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accession number M97297) and Aus0004 (2835430-2869240 bp) reference genomes, 142 
respectively, using the Snippy pipeline version 3.1. 143 
 144 
Results 145 
From January 2014 to May 2017, 156 patients were found infected/colonized with 146 
VREfm; the majority being hospitalized in the visceral surgery ward (n=76), the medical 147 
ward (n=33), the septic surgical ward (n=25) and the intensive care units (n=10). A 148 
total of 183 VREfm isolates were sequenced (one per patient for 146 patients, 2-17 149 
isolates for 10 patients). Outbreaks were defined on epidemiological links as described 150 
in Material and Methods. During the study period, a total of ten outbreaks were 151 
recorded (Figure 1 and Table S1). The median age of VREfm positive patients was 66 152 
years (range 1 to 96). The median number of days between patients’ admission and 153 
first detection of VREfm was 25 days (range 0 to 280). Moreover, temporary universal 154 
VRE screening of patients at admission in the surgical unit during six weeks revealed 155 
only one VREfm case out of 187, suggesting intra-hospital emergence of vancomycin-156 
resistance in E. faecium instead of importation. 157 
Population structure of VREfm within the hospital setting 158 
In silico MLST analysis revealed eleven different STs among the 156 patients: ST80 159 
(n = 77), ST117 (n = 36) and ST17 (n = 30) were the most prevalent STs, while few 160 
isolates were assigned to ST203 (n = 3), ST18 (n = 3), and ST192 (n = 2). In addition, 161 
ST82, ST182, ST412 and ST721 were represented each by a single isolate, and one 162 
remaining isolate had a novel ST (not assigned to any of the previously published STs) 163 
(Table S1). 164 
Recombination 165 
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Using Gubbins, a high rate of recombination events was detected, especially among 166 
VREfm isolates that belongs to ST80 (216 recombination events) and ST117 (95 167 
recombination events) (Figure S1). These recombination events were distributed over 168 
the entire genomes of both ST80 and ST117 and varied broadly in size between 19 bp 169 
to 109,812 bp and between 31 bp to 93,428 bp, respectively. The majority of these 170 
recombination events were due to the acquisition of insertion sequences that encode 171 
for antimicrobial resistance and phosphotransferase system (PTS). Consequently, the 172 
entire SNPs detected within the identified recombinant sequences were excluded from 173 
the final core-genome SNPs alignment that was used to build the phylogeny of the 174 
investigated VREfm isolates. 175 
Phylogenetic analysis 176 
The phylogenetic analysis based on core genome SNPs of the 183 VREfm revealed 177 
that isolate H32990 (ST82) was distantly related to the remaining 182 isolates and, 178 
therefore, was used as an outgroup to root the phylogenetic tree. Three major 179 
phylogenetic clades were identified, namely, clade ST117, clade ST17 and clade 180 
ST80-ST18 (Figure 2), which were correlated to the different successive VREfm 181 
outbreaks, suggesting clonal disseminations of different VREfm clones within the 182 
hospital. The monophyletic clade ST17 corresponded to the first and second outbreaks 183 
and consisted of 51 ST17 VREfm isolates with a median SNP difference of zero (range 184 
0-2), suggesting direct transmission between patients. 185 
In contrast, clade ST80-ST18 was subdivided into six distinct clusters (ST80-A, ST80-186 
B, ST80-C, ST80-D, ST80-E and ST18), which represented different lineages 187 
introduced into the hospital on different occasions (Figure 2). 188 
With exception of three isolates, all VREfm ST117 isolates were grouped into the same 189 
clade, which is subdivided into four distinct clusters (ST117-A, ST117-B, ST117-C and 190 
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ST117-D). Pairwise SNPs distance analysis revealed that isolates within each cluster 191 
of clades ST80-ST18 and clade ST117 were closely related with a median SNP 192 
difference of 0-2 SNPs (range 0-5), with exception of cluster ST117-D that had a range 193 
of 0 to 51 SNPs. This wide range of SNPs was due to isolate H32231, which is single 194 
locus variant from ST117 and differed by 49 to 51 SNPs compared to the remaining 195 
isolates within this cluster. Noteworthy, the inter-clades/clusters median SNPs 196 
differences were considerably high with up to 50 SNPs (range 2-82).  197 
Seventeen patients carried an isolate that was not closely related to another isolate 198 
(unique genotypes). 199 
Comparison between epidemiological and genotyping data 200 
The relation between outbreaks (documented based on epidemiological data) and 201 
genetic clusters (defined based on genomic data) is shown in Figure 3. This figure is 202 
highly informative. First, among the 129 cases involved in outbreaks, 109 (91%) 203 
belonged to the same genetic clusters. The remaining 20 cases (16%) could be 204 
excluded from the transmission chains because they carried an isolate genetically 205 
different. In four of the ten outbreaks, patients with a unique genotype or belonging to 206 
another cluster were observed, excluding these cases from the transmission chain. 207 
More interesting, on one occasion, a small outbreak (#1, Figures 1 and 3) was followed 208 
two months later by a larger outbreak (#2), suggesting the resurgence of transmission 209 
that was considered under control. On the other hand, among the 27 cases with no 210 
epidemiological link with other cases (singles), only 12 carried a unique VRE genotype, 211 
the other 15 carried isolates genetically highly similar to isolates from other cases, 212 
strongly suggesting they were associated to some putative chains of transmission. We 213 
also observed patients hospitalized at different times, with no obvious epidemiological 214 
link, but carrying isolates belonging to the same cluster and therefore putative 215 
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transmission (ST80-A, ST117-C, ST117-D and ST117-E). The most striking example 216 
is cluster ST117-D which was first observed in a single case in March 2016, followed 217 
by 5 cases between October 2016 and January 2017 that were detected during weekly 218 
screenings performed to control outbreak #8 (cluster ST80-D), and a last case in May 219 
2017. These observations strongly suggest the existence of undetected carriers. 220 
Genetic characterisation of VRE isolates 221 
In this study, the antimicrobial resistance genes detected in the 183 VREfm isolates 222 
genomes are summarized in Table S2. The majority harboured the vanA gene (91.3%), 223 
whereas the remaining 8.7% carried the vanB gene. In addition, the presence or 224 
absence of antimicrobial resistance genes was consistent within each cluster (Table 225 
S2). 226 
To estimate the number of different origins of the van genes in our isolates' collection, 227 
the genetic contents of van transposon were investigated. Sixteen isolates carried the 228 
vanB genes and constituted clusters ST18, ST117-A and ST117-B. Mapping the vanB 229 
transposon of these isolates against the vanB transposon of the reference genome 230 
AUS004 (GenBank accession number: NC-017022) grouped the isolates into three 231 
distinct clusters with 8 to 11 SNPs differences among them. The tree topology agreed 232 
with the core-genome SNPs phylogeny (Figure S2). Similar analysis was performed 233 
with the vanA transposon, showing a limited diversification (zero to five SNPs) and no 234 
correlation with clusters (data not shown). 235 
Several genes conferring resistance to various aminoglycosides were detected among 236 
the isolates collection. Most of these genes were associated with particular 237 
phylogenetic clusters. For example, all 33 isolates belonging to cluster ST80-D lacked 238 
the high-level gentamicin resistance aac(6΄)-aph(2″) gene, which was detected in 47% 239 
(86/183) of the isolates. Similarly, isolates from clusters ST80-C and ST80-D lacked 240 
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both sat4 and aph(3′)-IIIa genes, while ST17 isolates lacked the ant(6′)-Ia gene that 241 
mediate only high-level streptomycin resistance; these genes were detected in 47.5% 242 
(87/183), 53% (97/183) and 67% (128/183) of the investigated isolates, respectively. 243 
The msrC, ermA, ermB, and ermC genes that confer resistance to macrolides were 244 
detected in 100% (183/183), 0.5 % (1/183), 98% (180/183) and 4.9% (9/183) of the 245 
investigated VREfm isolates, respectively. The dfr gene, that encodes resistance to 246 
trimethoprim, was found in 46.5% (85/183) of the isolates. Of note, all isolates 247 
belonging to clade ST17 and cluster ST117-D lacked this gene.  248 
Interestingly, mutations in liaS gene and/or liaR conferring resistance to daptomycin 249 
were detected in 20% (37/183) of isolates, which all but one belonged to ST80 and 250 
were mainly located in clusters ST80-B and ST80-D. 251 
Similarly, screening all the 183 VREfm for putative virulence factors genes using the 252 
Virulence Factor Database (VFDB) (17) revealed that all isolates but two harboured 253 
the acm gene. In addition, clusters ST80-B and ST80-D isolates lacked pilin gene 254 
cluster, while the ecbA gene was present in > 50% of isolates but was absent from 255 
ST17 isolates (Table S2). 256 
In-host evolution 257 
To investigate the in-host diversity and the evolution of VREfm within host, we analysed 258 
36 isolates that were sampled between 0 to 391 days apart from nine patients (P003 259 
[n = 2], P008 [n = 2], P009 [n = 17], P020 [n = 2], P025 [n = 2], P033 [n = 5], P037 [n 260 
= 2], P089 [n = 2] and P159 [n = 2]). For Patient P009, on two occasions, different 261 
colonies from the same sample were isolated for WGS (P009-02 to P009-05; and 262 
P009-08 to P009-16, Figure 2). For six patients, phylogenetic analysis revealed 263 
evidence of restricted numbers of in-host variations: isolates sampled up to 391 days 264 
apart differed by only 0 to 3 SNPs. Evidence for multiple colonization was found in 265 
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patients P033 and P089. Over a period of 370 days, P033 was simultaneously 266 
colonized by two different genotypes ST80-A and ST80-B which differed by a mean of 267 
20 SNPs.  The two isolates from P089 were obtained 182 days apart and belonged to 268 
two different genotypes (unique and ST117-C; 42 SNP differences), suggesting 269 
successive colonization by different genotypes. 270 
Evidence of in-host recombination was found in patients P037 and P089. After 271 
excluding the SNPs located within recombinant genomic regions, four (P037) and 42 272 
(P089) SNPs differences were detected among the repetitive isolates from these 273 
patients. 274 
Infection control 275 
These outbreaks led to reinforcement of infection control measures in units with VRE 276 
cases, including information, training and observations of health care workers. 277 
Procedures for disinfection of the patient’s environment were reinforced, and additional 278 
staff was dedicated to this task. Weekly screenings by culture of all patients were 279 
performed until two weeks passed without any new case. In addition, patients in units 280 
with recurrent VRE outbreaks were screened on a weekly basis for several months. 281 
We also transformed some of the 5-bed rooms into 2-bed rooms with sanitation. Since 282 
the introduction of these infection control measures, a marked decrease in new cases 283 
has been observed (N=16, including only three small outbreaks of 2, 2 and 3 cases) 284 
during the year following this study. 285 
 286 
Discussion: 287 
Using WGS analysis, we prospectively investigated the epidemiology of VREfm at the 288 
University hospital of Lausanne over a period of three years. Among the 156 studied 289 
patients, thirteen clusters (genotypes) of genetically highly related isolates were 290 
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involved in the sequential outbreaks, suggesting several independent introductions of 291 
VRE isolates into the hospital followed by direct or indirect transmission. These findings 292 
are supported by previous studies, which revealed the emergence of several VREfm 293 
clones within hospitals through multiple independent introductions followed by intra-294 
hospital transmissions (6, 7, 18, 19). 295 
Our results showed that 91% of the cases involved in outbreaks were confirmed by 296 
WGS results. Moreover, isolates of the same outbreak differed by only 0 to 3 SNPs, 297 
which is in agreement with the estimated molecular clock rate of ~10 SNPs per genome 298 
per year (19). Conversely, based on WGS results, we were able to completely exclude 299 
patients from a chain of transmission when they were harbouring a different genotype. 300 
Moreover, WGS highlighted the co-circulation of several genotypes in some wards. For 301 
example, during outbreaks #3 and #9 (four patients each), only one transmission was 302 
confirmed, whereas during outbreak#7, two genotypes (ST80D and ST117-D) were 303 
spreading concomitantly in the ward.  304 
Another added value of WGS analysis lies in its very high discriminatory power, which 305 
enables to cluster patients for whom no apparent epidemiological link was recorded. 306 
For example, WGS linked the first large outbreak in January 2015 to two 307 
epidemiologically unsuspected cases in November 2014, which highly suggests the 308 
presence of undetected cases between both episodes. This is corroborated in our 309 
study by the presence of several patients hospitalized at different times, with no 310 
obvious epidemiological link, but carrying isolates belonging to the same cluster. The 311 
hypothesis of a persistent contamination of the environment was considered. Several 312 
other factors contributing to the spread of VREfm were also identified: i) multiple 313 
movements of patients within the hospital, ii) five-bed rooms and open units, iii) lack of 314 
individual toilet facility, iii) suboptimal disinfection of the environment. Interestingly, 315 
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VREfm cases transferred from a foreign hospital, for whom contact precautions were 316 
taken since admission, had a unique genotype, suggesting they were not the source 317 
of transmission to other patients. 318 
Investigating the in-host evolution of VREfm revealed that most patients carried 319 
isolates with only 0 to 3 SNP differences despite long period of carriage (up to 391 320 
days). Analysing various repetitive isolates from the same sample showed a small 321 
number of SNP difference emphasising that patients harbour a collection of VREfm 322 
isolates that have evolved independently following the first colonization/infection event. 323 
Conversely, different genotypes were observed for two patients, suggesting 324 
colonization on different occasions from various sources. These findings are consistent 325 
with previous studies that suggested the carriage of several VREfm lineages by 326 
patients (7, 20). Hence, a larger number of sequenced isolates per sample and per 327 
patient are required to better characterize the in-host population dynamic of VREfm. 328 
Of note, recombination between patient's isolates was observed, highlighting the 329 
necessity to consider this diversification process when analysing SNP similarity 330 
between isolates.  331 
The diversity of genotypes within our population of patients raised the question of their 332 
emergence. Van Hal et al. (21) hypothesised that the emergence of new clone is a 333 
result of continuous recombination. Our study supports this hypothesis since a high 334 
recombination rate was observed among the investigated isolates. Moreover, recent 335 
studies showed that resistance to vancomycin is repeatedly introduced in the E. 336 
faecium population (7, 19). A limitation of these studies was that only blood culture 337 
isolates were included and carriage isolates were missing. Our study includes carriage 338 
isolates and we identified various resistance patterns that were lineage specific, 339 
emphasizing the role of horizontal gene transfer in the emergence of new genotypes. 340 
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However, the limitation of our study to investigate this hypothesis resides in the lack of 341 
sequencing isolates of E. faecium susceptible to vancomycin. Together, these findings 342 
suggest the common de novo emergence of VREfm. The time elapsed between 343 
patients’ admission and first VREfm detection (median 26 days) and the fact that only 344 
one patient out of 187 was positive for VREfm at admission in a unit with recurrent 345 
outbreaks suggest that the emergence occurred within the hospitalized patients. 346 
Therefore, control measures should focus on (i) the prevention of VREfm emergence 347 
with an effective antibiotic stewardship program and (ii) a bundle of infection control 348 
actions to prevent cross transmission, particularly with early identification of cases by 349 
repeated screening throughout the hospitalization as well as prompt implementation of 350 
contact precautions. 351 
In conclusion, WGS of all VREfm isolates enable us to better understand our local 352 
epidemiology. Of interest, sporadic cases were often found to be related to a past or 353 
future outbreak. The polyclonal structure observed between the different outbreaks, 354 
the high level of recombination detected in studied isolates, the time elapsed between 355 
admission and the first VREfm detection and the negative screening at admission 356 
support the hypothesis of the emergence of new VREfm clones within hospitalized 357 
patients. 358 
 359 
  360 
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Figure legends 445 
 446 
Figure 1. Incidence of VREfm cases and outbreaks identified with epidemiological 447 
data. 448 
 449 
Figure 2. Maximum likelihood tree based on core-genome SNPs in the 182 450 
vancomycin-resistant Enterococcus faecium isolates collected in 156 patients from 451 
January 2014 to May 2017. MLST sequence type, isolate number and patient number 452 
are indicated. Isolates carrying the vanA gene are in black and vanB in red. A "$" 453 
indicates isolates retrieved at admission of patients transferred from a foreign hospital. 454 
 455 
Figure 3. Distribution of the different genetic clusters within outbreaks defined by 456 
epidemiological data 457 
 458 
 459 
Supplementary materials 460 
Figure S1. Phylogenetic tree of the 183 vancomycin-resistant Enterococcus faecium 461 
isolates inferring recombination events using Gubbins. Red blocks represent regions 462 
of high SNPs density detected in multiple isolates, while blue blocks represent high 463 
SNPs density only found in a single isolate. 464 
Figure S2. Phylogenetic tree reconstruction of 16 VREfm isolates based on core SNPs 465 
in vanB Tn1549.  466 
Table S1. Patient's epidemiological data. 467 
Table S2. Entire resistance and virulence factors detected in the 183 VREfm isolates. 468 
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Figure S1. Phylogenetic tree of the 183 vancomycin-resistant Enterococcus faecium isolates inferring recombination events using Gubbins. Red blocks 
represent regions of high SNPs density detected in multiple isolates, while blue blocks represent high SNPs density only found in a single isolate.
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Figure S2. Phylogenetic tree reconstruction of 16 VREfm isolates based on core SNPs in vanB Tn1549.
